Tolaney SM, Guarneri V, Seo JH, Cruz J, et al. Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer. Eur J Cancer 2024;199:113555.
PMID: 38244363